VYCOR MEDICAL INC - 10-Q Filing
Vycor Medical, Inc. reports financial results for the fiscal quarter ended September 30, 2026.
Tickers: $VYCO
Read the full article at SEC EDGAR
Part of the story Elite Pharmaceuticals Reports Q2 Revenue Growth and Net Income of $17.3 Million (3 articles)